SALUCK RANDY S. 4
4 · Statera Biopharma, Inc. · Filed Oct 28, 2021
Insider Transaction Report
Form 4
SALUCK RANDY S.
Director
Transactions
- Award
Common Stock, par value $0.005 per share
2021-09-09+60,000→ 60,140 total
Footnotes (2)
- [F1]These securities are restricted stock units (RSUs) that were granted pursuant to the Cleveland Biolabs, Inc. Equity Incentive Plan. The RSUs will be settled solely with Issuer Common Stock and vest in equal monthly portions over the period of 36 months from the grant date, provided that the Reporting Person continues to provide services to the Issuer through each vesting date.
- [F2]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Issuer Common Stock, subject to the applicable vesting schedule and conditions of each RSU.